-
Policy
Policy
Exclusive interviews with leading policymakers that convey the true policy message that impacts markets.
LATEST FROM POLICY: -
EM Policy
EM Policy
Exclusive interviews with leading policymakers that convey the true policy message that impacts markets.
LATEST FROM EM POLICY: -
G10 Markets
G10 Markets
Real-time insight on key fixed income and fx markets.
Launch MNI PodcastsFixed IncomeFI Markets AnalysisCentral Bank PreviewsFI PiFixed Income Technical AnalysisUS$ Credit Supply PipelineGilt Week AheadGlobal IssuanceEurozoneUKUSDeep DiveGlobal Issuance CalendarsEZ/UK Bond Auction CalendarEZ/UK T-bill Auction CalendarUS Treasury Auction CalendarPolitical RiskMNI Political Risk AnalysisMNI Political Risk - US Daily BriefMNI Political Risk - The week AheadElection Previews -
Emerging Markets
Emerging Markets
Real-time insight of emerging markets in CEMEA, Asia and LatAm region
-
Commodities
-
Credit
Credit
Real time insight of credit markets
-
Data
-
Global Macro
Global Macro
Actionable insight on monetary policy, balance sheet and inflation with focus on global issuance. Analysis on key political risk impacting the global markets.
Global MacroDM Central Bank PreviewsDM Central Bank ReviewsEM Central Bank PreviewsEM Central Bank ReviewsBalance Sheet AnalysisData AnalysisEurozone DataUK DataUS DataAPAC DataInflation InsightEmployment InsightGlobal IssuanceEurozoneUKUSDeep DiveGlobal Issuance Calendars EZ/UK Bond Auction Calendar EZ/UK T-bill Auction Calendar US Treasury Auction Calendar Global Macro Weekly -
About Us
To read the full story
Sign up now for free trial access to this content.
Please enter your details below.
Why MNI
MNI is the leading provider
of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.
Real-time Actionable Insight
Get the latest on Central Bank Policy and FX & FI Markets to help inform both your strategic and tactical decision-making.
Free AccessBayer (BAYNGR: Baa2 neg /BBB/BBB): 2Q24 Preview
- BASF saw Agriculture underperform by 8.4% vs expectations. This does not bode well for Bayer where Crop Science is c.49% of overall revenues. This may be mitigated by the 1Q skew on that sector. The market is anticipating 2Q24 Crop Science to be down only -1% on 1Q23... This may be overly optimistic.
- Pharma - Blockbusters Xarelto and Eylea will continue to lose revenues with drops of -12% and -2% expected vs 1Q23. Nubeqa and Kerendia are expected to have expanded 55-60% but this will still leave Pharma -4% y-o-y
- Litigation. Bayer had €11.1bn in "other provisions" - current & non-current combined as of 1Q24. RoundUp is normally around 60% of these. It has had recent successes in this field including having a case dismissed in Australia. 113,000/170,000 cases had settled as of 1Q24.On the other hand, PCB (forever chemicals) cases may increase. Note $160m payment in Seattle yesterday.
- Total Revenue expected €10.9b (-1.4%); Adj EBITDA €2.1b (-16%), Net Debt/EBITDA 3.6x (up 0.3%) On the positive side, total debt will decline due to the dividend cut by around €3bn yoy.
- Excluding Hybrids - Weighted Average Debt Maturity is 7.1yrs with $1.75bn due in Oct '24 and €1.2bn in Jan '25. Last raised $5.75b in Oct 23 with significant maturities in Dec '23 to pay.
To read the full story
Sign up now for free trial access to this content.
Please enter your details below.
Why MNI
MNI is the leading provider
of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.